Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2007
11/21/2007EP1855708A1 Treating anemia by inhibition of vegf
11/21/2007EP1855661A1 Formulation for aviptadil
11/21/2007EP1534707B1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007EP1385498B1 Fatty acids as neutrophil survival and activation factors.
11/21/2007EP1356071B1 Genetically engineered herpes virus for the treatment of cardiovascular disease
11/21/2007EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/21/2007EP1150996B1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
11/21/2007EP0529031B9 Improved inhibitors of thrombin
11/21/2007CN101076519A Amide compound and thrombopoietin receptor activator
11/21/2007CN101076325A Medicinal composition of edible carboxylic-acid and/or its acid salts and caffeine and non-drug addiction coffee
11/21/2007CN101074447A Method for producing paeonin metabolite-I by short lactobacillin fermentation
11/21/2007CN101074437A Reptilase I-type enzyme products and its production
11/21/2007CN101074271A Production and use for amphipathic chitose derivative
11/21/2007CN101074268A Tranduced peptide-huamn erythrogenin fusion protein and its medicinal composition
11/21/2007CN101073666A Method for producing high-purity kallidin proenzyme raw-material medicine
11/21/2007CN101073597A Medicinal composition for contracting uterus, stopping blood and regulating emmenia and its production
11/21/2007CN101073428A Hongjingtian Chinese-medicinal beverage
11/21/2007CN101073398A Yellow-peach can
11/21/2007CN101073365A Lily health-care heat-clearing tea and its production
11/21/2007CN101073364A Production of sweet-potato leaf health-care tea
11/21/2007CN100349893C Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007CN100349612C Sustained releasing microspheric preparation of glucokinase mutant and its making method
11/20/2007US7297818 Adamantane derivatives
11/20/2007US7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
11/20/2007US7297706 Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297332 Protease, a gene therefor and the use thereof
11/20/2007CA2262409C Modified tie-2-receptor ligands
11/20/2007CA2186126C Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
11/15/2007WO2007129618A1 Inhibitor of neutrophil activation/migration factor and use thereof
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007WO2007129019A1 Sulfonamide compounds useful as edg receptor modulators
11/15/2007WO2007128926A1 Paste for use as a bandage on mucous membranes of the oral cavity or on the skin
11/15/2007WO2007128454A1 3-tetrazolyl indazoles, 3-tetrazolyl pyrazolopyridines, and use thereof
11/15/2007WO2005092369A3 Conjugates of hydroxyethyl starch and erythropoietin
11/15/2007WO2002089799A3 Use of dihydropyrazoles to increase erythropoietin and vasculari zation
11/15/2007US20070265331 Such as (2S)-2-(3(S)-Acetylamino-3-((S)-sec-butyl)-2-oxo-pyrrolidin-1-yl)-N-[(1S,2R)-1-(3,5-difluoro-benzyl)-2-hydroxy-3-(3-methoxy-benzylamino)-propyl]-4-phenyl-butyramide; inhibit processing of amyloid precursor proteins
11/15/2007US20070265327 For therapy of neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal
11/15/2007US20070265323 Compounds for the treatment of metabolic disorders
11/15/2007US20070265322 Compounds for the treatment of metabolic disorders
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265298 Preparation and Use of Biphenyl-4-Yl-Carbonylamino Acid Derivatives for the Treatment of Obesity
11/15/2007US20070265283 Xanthine Oxidase Inhibitor
11/15/2007US20070265282 Use of ticagrelor treating myocardial infarction, thrombotic stroke, angina and transient ischemic attacks
11/15/2007US20070265280 Methods of using sodium channel blockers
11/15/2007US20070265263 Heterocyclic inhibitors of ERK2 and uses thereof
11/15/2007US20070265208 Association of calpain inhibitors and reactive oxygen species trapping agents
11/15/2007US20070265207 Treating nocturia, primary nocturnal enuresis, or incontinence, or for inducing voiding postponement; a steady plasma/serum desmopressin concentration in the range of from about 0.1 picograms desmopressin per mL plasma/serum to about 10.0 picogram desmopressin per mL plasma/serum
11/15/2007US20070265201 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
11/15/2007US20070265199 comprising an A1 domain having a calcium binding site; hemophilia A; antihemophilia agents
11/15/2007US20070264417 Procyanidins; cleaning cocoa beans, heating unroasted cocoa nibs to loosen shells, winnowing the nibs from the shells, extracting with a polar solvent, a non-polar solvent, or a supercritical fluid
11/15/2007US20070264336 Hydrophilic/lipophilic polymeric matrix dosage formulation
11/15/2007US20070264240 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation
11/15/2007US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
11/15/2007US20070264194 Peptides That Bind To Atherosclerotic Lesions
11/15/2007CA2651556A1 3-tetrazolylindazoles and 3-tetrazolylpyrazolopyridines and their use
11/14/2007EP1854483A1 Agent for control of function of antigen-presenting cell
11/14/2007EP1854482A1 Agent for control of degranulation reaction and cytokine production
11/14/2007EP1853267A1 Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1853253A1 Diosmetin derivatives for the treatment and prevention of thrombotic pathologies
11/14/2007EP1853235A1 Methods for improving drug disposition
11/14/2007EP1495018B1 Tricyclic thrombin receptor antagonists
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007EP1423012B1 Medical use of stem cells expressing vegfr-1
11/14/2007EP1343903B1 A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell
11/14/2007EP1286691B1 Methods for treatment of diseases associated with acute inflammation under non-ischemic conditions
11/14/2007EP1235592B1 Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament
11/14/2007EP1034189B1 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
11/14/2007CN101072772A 凝血酶受体拮抗剂 Thrombin receptor antagonists
11/14/2007CN101072769A Antiplatelet agent and process for producing the same
11/14/2007CN101069740A Medicine for preventing and treating fowl's ascites and preparing method
11/14/2007CN101069680A Preparation of 2-hydroxyl-methyl benzenesulfonic acid preparation and use thereof
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/14/2007CN100348583C Novel enantiomer of tetra hydrogen isoquinoline derivative and officinal salt, preparation and pharmaceutical composition thereof
11/14/2007CN100348568C Process for extracting high purity alpha-linolenic acid from pepper category and medicine application thereof
11/14/2007CN100348267C Purification of red blood cells by separation and infiltration
11/14/2007CN100348256C Gynecology restringent
11/13/2007US7294720 N3-(hydroxy- or alkoxyphenyl) amidrazone, e.g., N3-[3-Methoxyphenyl]-p-tert-butyl-benzamidrazone, are intermediates for preparing phenyl-1,2,4-triazoles, e.g., 1-{3-[4-(tert-Butyl)phenyl]-(1,2,4-triazol-4-yl)}-3-methoxybenzene
11/13/2007US7294718 Synthesis of a 4-methylthiazole-4(S)-carboxylic acid compound
11/13/2007US7294715 E.g., 2,9-Diisopropyloxy-1,10-dimethoxy-7-oxoaporphine and 1-methoxy-2-hydroxy-9,10-methylenedioxyaporphine; are used to treat ischemic and metabolic diseases
11/13/2007US7294699 Factor vii or factor ix polypeptides; enhanced membrane binding; blood disorders; blood coagulation
11/13/2007US7294627 Factor Xa inhibitors, useful in therapy of thrombotic disorders
11/13/2007US7294618 Glucopyranosyloxypyrazole derivatives and medicinal use thereof
11/13/2007CA2169451C Biochemically balanced peritoneal dialysis solutions
11/12/2007WO2007132785A1 Agent for preventing organ adhesion and method for preventing adhesion using the same
11/12/2007CA2652322A1 Organ-adhesion preventing agent and process for preventing adhesion using thereof
11/08/2007WO2007127377A2 Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease
11/08/2007WO2007127298A2 Pucoidans for reducing blood coagulation
11/08/2007WO2007066017A3 Method for preparing a factor h concentrate and the use thereof in the form of a drug
11/08/2007WO2007009895A3 USE OF FACTOR VIIa OR FACTOR VIIa EQUIVALENTS FOR PREVENTING OR ATTENUATING HAEMORRHAGE GROWTH, AND/OR OEDEMA GENERATION FOLLOWING INTRACEREBRAL HAEMORRHAGE (ICH) IN PATIENTS TREATED WITH ANTIPLATELET THERAPY
11/08/2007US20070259955 Process for the Preparation of Nateglinide
11/08/2007US20070259904 Bi-aryl meta-pyrimidine inhibitors of kinases
11/08/2007US20070259887 Inhibitors of polyq-aggregation
11/08/2007US20070259882 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
11/08/2007US20070259854 Triazole Derivative or Salt Thereof
11/08/2007US20070259815 Albumin fusion proteins
11/08/2007US20070259809 Methods of Using High Affinity Atiii Variants
11/08/2007US20070259050 Combined Cosmetic or Therapeutic Preparation
1 ... 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 ... 671